Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Response of Refractory New Daily Persistent Headache to Intravenous Lidocaine Treatment in a Pediatric Patient

Asra Akbar1,2*

1Department of Headache Medicine, Baylor University Medical Center, Baylor Scott & White Healthcare, Dallas, TX, USA

2Department of Pediatric Neurology, University of Illinois College of Medicine, Peoria, IL, USA

*Corresponding Author:
Asra Akbar
Department of Pediatric Neurology, University of Illinois College of Medicine
420 NE Glen Oak Avenue, Suite 401, Peoria, IL 61603, USA
Tel: 314-753-0079
E-mail: dr_aakbar@yahoo.com

Received date: February 21, 2017; Accepted date: July 21, 2017; Published date: July 26, 2017

Citation: Akbar A (2017) Response of Refractory New Daily Persistent Headache to Intravenous Lidocaine Treatment in a Pediatric Patient. J Pain Relief 6:297. doi:10.4172/2167-0846.1000297

Copyright: © 2017 Akbar A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

New daily persistent headache (NDPH) is defined as a persistent and daily headache from onset. It is a unique headache that typically seen in people without a prior history of headaches. New daily persistent headache (NDPH) is an often medication-refractory headache disorder, currently classified as a primary headache disorder. Several medications including Onabotulinum toxin injections and sphenopalatine ganglion block are currently under investigation and may provide a potential new effective treatment regimen. IV lidocaine has been used for the management of chronic daily headaches, trigeminal autonomic cephalalgias, neuropathic pain, oro-facial, and postoperative pain. We administered IV lidocaine with successful treatment of headache in a refractory NDPH pediatric patient.

Keywords

Recommended Conferences
Google Scholar citation report
Citations : 1556

Journal of Pain & Relief received 1556 citations as per Google Scholar report

Journal of Pain & Relief peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Cosmos IF
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page
Top